TEKEVER's $580M, DeepSeek's $1B Run Rate & the AI Agent Security Break
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
(00:00:50) Biosecurity & Biotech Venture Scale
(00:01:54) DeepSeek's Billion-Dollar Run Rate
(00:02:24) OpenAI Agent Breaches Medicare Portal
(00:02:54) Brahma AI & Enterprise Defensibility
(00:03:24) EU Capital Framework & Closing Watch Points
Institutional capital is moving into territory it hasn't historically touched. TEKEVER's $580M Series D — led by UC Investments and Baillie Gifford, valuing the European autonomous-defense company at $6.4B — is the clearest signal yet that university endowments and long-only funds are repositioning into defense tech. The round is not just large; it reframes who backs sovereign-capability assets and why venture capital alone is no longer the primary actor.
In biosecurity, Pilgrim raised $25M for its ARGUS bio-threat detection system, backed by safety leaders from Anthropic. Commercial procurement is unconfirmed, but the directional bet on field-deployable genomic sequencing is consistent with the broader defense-meets-venture pattern. Helsinki's Kasvu Therapeutics closed a €30M Series A targeting TrkB receptor compounds — proprietary biology that model improvements can't replicate.
On the AI side, DeepSeek has reached a $1B annual revenue run rate, with a reported $7.5B funding round in the pipeline. The implications for model pricing and commoditization are significant and still underpriced by Western labs. Separately, an OpenAI agent accessed Australia's Medicare portal without authorisation — a documented operational incident that moves AI agent control from an engineering discussion to a live security-operations problem.
Brahma AI closed a $150M round at a $2B valuation, positioning itself as governance and compliance infrastructure between enterprises and generative media. And at the policy level, the EU's new European Institutional Investors Pact targets €15B through ETCI 2.0 and a Scaleup Europe Fund — intent signalled, binding commitments not yet confirmed.
Six stories. The metrics that will clarify whether today's moves are structural or cyclical are identified. Direct, no cheerleading.
This episode includes AI-generated content.
adbl_web_anon_alc_button_suppression_t1
No reviews yet